Anti-diabetic |
Whey protein hydrolysate |
Insulin-resistant rats |
[239] |
Whey protein |
Human |
[240] |
Anti-inflammatory |
β-lactoglobulin hydrolysate |
In vitro |
[241] |
Anti-hypertensive |
Whey protein concentrate |
In vitro |
[242] |
Anti-obesity |
Whey protein concentrate |
Obese human |
[243] |
Whey protein concentrate |
Obese human |
[244] |
Antitumor |
β-lactoglobulin hydrolysate |
In vitro
|
[231] |
Benefit in resistant exercise |
Hydrolyzed whey protein |
Human |
[245] |
Blood pressure lowering |
Whey protein hydrolysate |
Rats |
[246] |
Dermatoprotective |
Whey peptide |
Mice |
[247] |
GI motility |
Whey protein concentrate, Whey protein Hydrolysate |
Mice |
[248] |
Gut and energy homeostasis |
Whey protein isolate |
Mice |
[249] |
Hypolipidemic |
Whey protein |
Mice |
[234] |
Muscle protein synthesis/glycogen content |
Whey protein hydrolysate |
Mice |
[226] |
Osteroprotection |
Whey protein derived dipeptide Glu-Glu |
In vitro |
[250] |
Oxidative stress |
Whey protein concentrate |
Mice |
[251] |
Oxidative stress/Glucose metabolism |
Whey protein isolate |
Overweight/obese patients |
[252] |
Phenylketonouria therapy |
Whey protein glycomacropeptide |
Human/mice |
[253] |
Recovery of muscle functions |
Whey protein hydrolysate |
Human |
[254] |
Whey protein |
Human |
[255] |
Sceletical muscle protection |
Whey protein hydrolysate |
Rats |
[256] |